Clinical ResearchJoin a study
Join a clinical study in Orlando at OIC
Join a clinical study in Orlando and be part of the research that shapes the future of medicine, with expert care, at no cost to you.
Participation benefits
What you can expect as a participant
- Study medications provided at no cost
- Study-related labs provided at no cost
- Study-related visits provided at no cost
- Monitoring by study-related providers
- Transportation assistance, when needed, through Lyft, Uber, or bus passes
- Stipend provided at each study visit
Now enrolling
Clinical studies in Orlando currently accepting participants
Merck-011 · Once-Monthly Oral PrEP Study (EXPRESSIVE)
A single tablet, once a month, for HIV prevention. This Phase 3 study evaluates MK-8527, an oral medication taken once monthly as HIV pre-exposure prophylaxis (PrEP) — an alternative to daily pills or injections. Route: Oral tablet, once monthly Length: Screening up to 45 days; treatment phase 30 months with 28-day follow-up Compensation: Stipend provided at each study visit You may pre-qualify if you are HIV-negative and at increased risk of HIV exposure. Contact our team for a confidential pre-screening. Protocol: MK8527-011 · Phase 3 · Sponsor: Merck
I’m interested →ViiV-222794 · QUATRO: Ultra Long-Acting HIV Maintenance
A Phase 3, randomized, multicenter, open-label, non-inferiority study evaluating cabotegravir ultra long-acting plus rilpivirine ultra long-acting (or cabotegravir long-acting plus rilpivirine long-acting) in adults and adolescents with HIV who are virologically suppressed on ART. Route: IM Length: 35 months Compensation: Stipend of $100 for scheduled/unscheduled visits, $200 for complicated visits (screening, baseline, Month 3, Month 7, and pregnancy LTFU), $25 for telephone contacts. Protocol: GSK222794 · Phase 3 · Sponsor: ViiV/GSK
I’m interested →Tell us about you
Pre-screening interest form
Referring a participant?
Are you a provider or community organization? Refer a potential participant to our team and we’ll take care of the rest. Call 407-647-3960 or use the contact form.